EECP Improves Exercise Capacity and Quality of Life of Patients with Heart Failure 體外反搏治療顯著改善心臟衰竭患者的運動能力和 生活品質

Source From 資料來源 : https://onlinelibrary.wiley.com/doi/full/10.1111/j.1527-5299.2002.01731.x?sid=nlm%3Apubmed

EECP Improves Exercise Capacity and Quality of Life of Patients with Heart Failure

To assess the feasibility of using enhanced external counterpulsation to treat patients with heart failure, 26 patients with stable heart failure (New York Heart Association classes II-III), with a left ventricular ejection fraction at or below 35%, and without fluid overload, were treated with enhanced external counterpulsation (1 hour daily, 5 days a week, to a total of 35 hours). Patients were followed for 6 months after completing the course of enhanced external counterpulsation. The primary parameter was safety as reflected by adverse events or by changes in laboratory parameters. Secondary end points included changes in exercise capacity and quality of life. There were no clinically significant problems associated with the administration of enhanced external counterpulsation. Significant improvements were seen in exercise capacity (peak oxygen uptake and exercise duration), and in quality of life assessments, at 1 week and 6 months after the course of enhanced external counterpulsation. This study suggests that enhanced external counterpulsation is safe and well tolerated in patients with stable heart failure, and that a randomized, controlled study of enhanced external counterpulsation in these patients is warranted.

「心臟衰竭患者的強化體外反搏:一項多中心可行性研究」

為了評估體外反搏治療心臟衰竭患者的可行性,26 名左心室射血分數在 35% 或以下、無體液超負荷的穩定型心臟衰竭患者(紐約心臟病協會 II-III 級)接受了體外反搏治療(每天 1 小時,每週 5 天,共 35 小時)。體外反搏療程結束後,對患者進行了為期 6 個月的隨訪。主要參數是安全性,通過不良事件或實驗室參數變化得知。實施體外反搏治療後,患者沒有出現明顯的臨床問題。在接受體外反搏治療 1 周和 6 個月後,患者的運動能力(峰值攝氧量和運動持續時間)和 生活品質 評估均有顯著改善。這項研究表明,體外反搏對穩定型心衰患者是安全且耐受性良好的,因此有必要對這些患者進行體外反搏的隨機對照研究。

×